Share This

Public company info - Shandong Xinhua Pharmaceutical Co. Ltd. - H Shares , 00719.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Shandong Xinhua Pharmaceutical Co. Ltd. - H Shares, 00719.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12 2006-12 2005-12
Net Cash Flow from Operating Activities 824,487 303,620 538,442 535,520 525,028 610,920 642,162 557,922 413,533 158,609 128,358 172,235 185,417 377,222 254,344 105,577 92,530 216,982
Net Cash Flow from Return on Investments & Servicing of Finance -190,153 -148,433 -143,287 -110,324 -103,810 -57,359 -94,257 -88,458 -85,566 -87,769 -78,476 -46,729 -28,844 -26,963 -24,242 -16,457 -27,653 -10,409
　Interest Received 0 0 0 0 0 0 0 0 4,811 3,674 3,020 2,206 2,631 1,929 3,617 3,958 9,721 11,757
　Interest Paid 0 0 0 0 0 -54,414 -70,111 0 -79,243 -75,692 -57,729 -27,971 -18,889 -19,101 -17,956 -12,183 -20,475 -22,166
　Dividend Received 0 0 0 7,514 0 0 0 0 4,137 3,898 2,572 1,899 5,994 5,549 4,022 914 141 0
　Dividend Paid -190,153 -148,433 -143,287 -117,838 -103,810 -2,945 -24,146 -88,458 -15,271 -19,649 -26,339 -22,863 -18,580 -15,340 -13,925 -9,146 -17,040 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -66,246 -44,503 -118,255 -187,249 -180,419 -220,948 -202,814 -209,286 -24,385 -16,839 -10,842 -25,055 -30,041 -13,393 -11,915 -11,510 -8,200 -5,388
Net Cash Flow from Investing Activities -228,902 -237,694 -298,005 -420,454 -398,350 -168,537 -243,293 -110,176 -449,223 -402,885 -535,174 -448,868 -205,627 -268,187 -312,008 24,473 -40,853 -46,301
　Additions to Fixed Assets -244,758 -249,227 -280,188 -366,512 -385,986 -261,108 -227,068 -169,086 -85,790 -68,332 -67,327 -444,758 -168,941 -194,760 -251,448 -112,344 -72,225 -109,751
　Disposal of Fixed Assets 7,938 2,428 3,594 2,825 6,511 53,345 5,922 33,278 4,725 60,103 76,095 1,695 7,132 2,527 1,955 12,545 8,624 16,546
　Increase in Investments 0 0 -30,000 -56,767 -19,629 0 -30,000 0 -102,000 0 -22,000 0 0 -636 -4,770 -12,823 -13,000 -10,000
　Decrease in Investments 0 0 8,589 0 7,155 9,227 7,853 20,334 2,280 0 0 11,613 518 569 -70 127,600 0 71,707
　Net Cash Flow with Related Parties 37,380 17,400 33,000 0 46,943 0 0 0 13,000 199,300 508,500 0 0 2,432 0 -6,969 3,003 0
　Others -29,462 -8,295 -33,000 0 -53,344 29,999 0 5,298 -281,438 -593,956 -1,030,442 -17,418 -44,336 -78,319 -57,675 16,464 32,745 -14,803
Net Cash Flow before Financing Activities 339,186 -127,010 -21,106 -182,507 -157,551 164,076 101,798 150,001 -145,641 -348,884 -496,134 -348,417 -79,095 68,679 -93,821 102,083 15,824 154,884
Net Cash Flow from Financing Activities 59,496 8,703 178,324 71,607 148,340 32,127 19,233 -75,091 136,303 245,407 603,712 248,313 82,767 112,052 77,655 -35,384 -180,732 -137,316
　New Loans 833,788 551,409 426,569 1,233,791 462,143 1,354,000 910,000 923,111 711,094 735,672 576,530 564,940 180,000 350,000 439,409 299,237 323,011 487,989
　Loans Repayment -888,672 -559,739 -729,656 -1,103,000 -267,838 0 -1,087,800 -939,689 -627,791 -790,056 -550,481 -352,000 -97,233 -240,380 -361,754 -327,652 -506,746 -625,305
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 -1,551,500 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 37,380 17,400 33,000 0 46,943 0 0 0 13,000 199,300 508,500 0 0 2,432 0 -6,969 3,003 0
　Others 77,000 -367 448,411 -59,184 -92,908 229,627 197,033 -58,513 40,000 100,491 69,163 35,373 0 0 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents 398,682 -118,307 157,218 -110,900 -9,211 196,203 121,030 74,911 -9,338 -103,477 107,578 -100,104 3,672 180,731 -16,166 66,699 -164,908 17,568
Cash & Cash Equivalents at Beginning of Year 596,392 722,563 577,625 687,243 682,863 493,093 366,639 281,435 311,026 414,488 267,966 368,070 364,398 183,667 199,833 133,134 298,042 280,474
Net Cash Flow due to Change in Exchange Rate/Others 15,691 -7,865 -12,280 1,281 5,807 -6,433 5,423 10,293 -9 15 0 0 0 0 0 0 0 0
Cash & Cash Equivalents at End of Year 1,010,764 596,392 722,563 577,625 679,458 682,863 493,093 366,639 301,679 311,026 375,544 267,966 368,070 364,398 183,667 199,833 133,134 298,042
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.